Skip to content

Enovis ENOV Current ratio

Current ratio at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-0.2×
Stryker logo
StrykerSYK
2.1×+0.5×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
1.7×-0.7×
ESAB logo
ESABESAB
+1.1×
Vericel logo
VericelVCEL
5.2×+0.2×
Globus Medical logo
Globus MedicalGMED
4.6×+0.1×

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×

Where this comes from

Calculated from Enovis’s reported figures.

Based on the most recent quarter.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's current ratio?
Enovis (ENOV) reported current ratio of 2× in Q1 2026.
How has Enovis's current ratio changed year-over-year?
Enovis's current ratio decreased by 20.2% year-over-year, from 2.6× to 2×.
What is the long-term trend for Enovis's current ratio?
Over 5 years (2020 to 2025), Enovis's current ratio has grown at a 3.8% compound annual growth rate (CAGR), from 1.7× to 2×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.